Watchlist Manager

Watchlist

Price: 10.83 CNY -0.09% Market Closed

Market Cap: ¥5.3B

	ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479	CN
A	Ameriwest Lithium Inc CNSX:AWLI	CA
	flatexDEGIRO AG XETRA:FTK	DE
	Peiport Holdings Ltd HKEX:2885	HK

Balance Sheet

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	93	73	71	378	404	401	397	507	185	275	119	151	183	227	513	728	427	961	1 114	587	510	1 102	1 928	1 336
Cash	0	0	0	0	0	0	0	0	0	0	0	20	11	37	4	3	5	6	3	4	510	1 102	1 928	1 336
Cash Equivalents	93	73	71	378	404	401	397	507	185	275	119	131	172	191	510	726	422	956	1 111	584	0	0	0	0
Short-Term Investments	0	0	0	6	6	59	130	0	232	60	99	93	22	70	31	8	182	173	0	753	789	674	0	5
Total Receivables	61	63	91	111	110	93	86	159	219	265	499	539	660	788	730	870	947	925	1 037	1 083	888	891	956	855
Accounts Receivables	38	44	63	57	46	37	22	25	30	31	37	55	81	97	125	143	155	192	223	242	224	255	250	255
Other Receivables	23	19	29	54	64	56	64	134	189	234	463	483	579	692	605	727	792	733	814	841	665	636	706	600
Inventory	78	71	85	84	75	87	83	97	99	127	117	195	223	243	272	359	376	441	470	497	548	599	534	486
Other Current Assets	18	6	11	36	25	14	15	26	32	30	29	79	37	115	382	169	496	96	335	269	182	248	96	48
Total Current Assets	249	213	259	615	620	653	712	789	766	757	863	1 056	1 125	1 444	1 928	2 133	2 429	2 596	2 955	3 189	2 917	3 513	3 514	2 729
PP&E Net	77	135	150	163	160	155	153	193	287	285	310	335	429	439	491	565	533	501	481	536	655	634	594	567
PP&E Gross	77	135	150	163	160	155	153	193	287	285	310	335	429	439	491	565	533	501	481	536	655	634	594	567
Accumulated Depreciation	36	45	61	81	93	116	131	149	166	190	225	257	304	338	377	413	454	496	539	587	649	726	802	844
Intangible Assets	5	5	5	5	4	20	20	47	48	47	45	200	253	247	260	260	241	286	255	216	220	222	238	237
Goodwill	0	0	0	0	0	9	9	9	9	9	9	9	14	14	14	14	14	14	14	14	14	14	14	14
Long-Term Investments	1	6	7	7	10	10	184	14	145	20	42	35	36	36	35	45	45	45	63	190	191	188	248	953
Other Long-Term Assets	1	2	1	4	4	7	7	8	11	12	13	11	40	49	14	15	24	30	44	83	63	64	68	56
Other Assets	0	0	0	0	0	9	9	9	9	9	9	9	14	14	14	14	14	14	14	14	14	14	14	14
Total Assets	333 N/A	360 +8%	421 +17%	793 +88%	798 +1%	853 +7%	1 085 +27%	1 059 -2%	1 266 +19%	1 129 -11%	1 282 +14%	1 645 +28%	1 898 +15%	2 229 +17%	2 743 +23%	3 032 +11%	3 287 +8%	3 473 +6%	3 812 +10%	4 229 +11%	4 060 -4%	4 635 +14%	4 677 +1%	4 556 -3%
Liabilities
Accounts Payable	46	39	52	58	50	70	69	79	87	81	80	81	113	127	163	249	231	486	229	286	273	318	294	279
Accrued Liabilities	70	50	52	50	44	54	47	49	37	54	89	46	62	59	47	58	90	102	99	124	146	214	232	220
Short-Term Debt	32	43	56	23	7	11	13	13	153	0	0	121	143	303	157	200	277	38	370	578	395	690	563	458
Current Portion of Long-Term Debt	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	22	21	22	21
Other Current Liabilities	23	39	25	14	101	32	37	41	35	28	92	303	320	269	294	330	335	329	403	389	393	454	431	354
Total Current Liabilities	171	171	185	145	201	167	166	181	312	162	262	551	639	759	662	837	934	956	1 101	1 378	1 228	1 697	1 542	1 333
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	32	54	47	37	27	21	20	60	45	38	26
Deferred Income Tax	0	0	0	0	0	4	21	0	0	0	0	0	4	4	4	7	6	7	9	11	13	24	25	18
Minority Interest	15	20	16	14	16	19	21	24	27	38	85	98	196	264	317	338	364	401	452	495	550	600	637	677
Other Liabilities	12	3	3	3	3	3	3	3	3	26	26	30	52	49	60	57	68	53	52	59	58	52	45	41
Total Liabilities	197 N/A	194 -2%	204 +5%	162 -21%	220 +36%	193 -12%	211 +9%	208 -1%	342 +64%	227 -34%	373 +65%	679 +82%	890 +31%	1 108 +24%	1 096 -1%	1 286 +17%	1 410 +10%	1 444 +2%	1 634 +13%	1 962 +20%	1 910 -3%	2 418 +27%	2 287 -5%	2 094 -8%
Equity
Common Stock	38	38	38	56	84	126	151	181	218	305	305	305	305	305	349	349	349	419	419	419	419	430	429	424
Retained Earnings	85	106	156	171	119	203	343	393	466	444	450	509	557	607	639	736	874	1 025	1 174	1 262	1 146	1 192	1 363	1 450
Additional Paid In Capital	12	22	23	404	376	332	380	277	240	153	153	152	147	210	659	661	654	585	585	585	585	635	631	603
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	2
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42	35	17
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0
Total Equity	135 N/A	166 +22%	217 +31%	631 +191%	579 -8%	661 +14%	875 +32%	851 -3%	924 +9%	902 -2%	908 +1%	966 +6%	1 008 +4%	1 122 +11%	1 647 +47%	1 746 +6%	1 877 +8%	2 029 +8%	2 178 +7%	2 267 +4%	2 150 -5%	2 217 +3%	2 390 +8%	2 462 +3%
Total Liabilities & Equity	333 N/A	360 +8%	421 +17%	793 +88%	798 +1%	853 +7%	1 085 +27%	1 059 -2%	1 266 +19%	1 129 -11%	1 282 +14%	1 645 +28%	1 898 +15%	2 229 +17%	2 743 +23%	3 032 +11%	3 287 +8%	3 473 +6%	3 812 +10%	4 229 +11%	4 060 -4%	4 635 +14%	4 677 +1%	4 556 -3%
Shares Outstanding
Common Shares Outstanding	248	248	248	366	366	366	366	366	366	366	366	366	366	366	419	419	419	419	419	419	419	419	419	424

Income Statement Balance Sheet Cash Flow Statement

ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479

Balance Sheet

Balance Sheet Decomposition
ZhuZhou QianJin Pharmaceutical Co Ltd

Balance Sheet
ZhuZhou QianJin Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

ZhuZhou QianJin Pharmaceutical Co Ltd SSE:600479

Balance Sheet

Balance Sheet Decomposition ZhuZhou QianJin Pharmaceutical Co Ltd

Balance Sheet ZhuZhou QianJin Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479

Balance Sheet Decomposition
ZhuZhou QianJin Pharmaceutical Co Ltd

Balance Sheet
ZhuZhou QianJin Pharmaceutical Co Ltd